A Randomized, Open-Label, Parallel Group, Drug-drug Interaction Study to Evaluate the Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Erdafitinib (Primary) ; Fluconazole; Itraconazole
- Indications Cancer; Cholangiocarcinoma; Gastric cancer; Liver cancer; Lymphoma; Multiple myeloma; Non-small cell lung cancer; Oesophageal cancer; Solid tumours; Urogenital cancer
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 20 Sep 2017 Status changed from recruiting to completed.
- 21 Aug 2017 Planned primary completion date changed from 31 Jul 2017 to 1 Sep 2017.
- 25 Jul 2017 Planned End Date changed from 31 Jul 2017 to 1 Sep 2017.